Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-life Efficacy of Omalizumab After 9 Years of Follow-up.
Menzella F, Galeone C, Formisano D, Castagnetti C, Ruggiero P, Simonazzi A, Zucchi L. Menzella F, et al. Among authors: simonazzi a. Allergy Asthma Immunol Res. 2017 Jul;9(4):368-372. doi: 10.4168/aair.2017.9.4.368. Allergy Asthma Immunol Res. 2017. PMID: 28497924 Free PMC article.
Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab.
Menzella F, Galeone C, Ghidoni G, Ruggiero P, Capobelli S, Simonazzi A, Catellani C, Scelfo C, Livrieri F, Facciolongo N. Menzella F, et al. Among authors: simonazzi a. Multidiscip Respir Med. 2021 Jun 24;16(1):779. doi: 10.4081/mrm.2021.779. eCollection 2021 Jan 15. Multidiscip Respir Med. 2021. PMID: 34221399 Free PMC article.
A Real-World Evaluation of Clinical Outcomes of Biologicals and Bronchial Thermoplasty for Severe Refractory Asthma (BIOTERM).
Menzella F, Fontana M, Galeone C, D'Amato M, Canonica GW, Ghidoni G, Capobelli S, Scelfo C, Simonazzi A, Catellani C, Ruggiero P, Facciolongo N. Menzella F, et al. Among authors: simonazzi a. J Asthma Allergy. 2021 Aug 13;14:1019-1031. doi: 10.2147/JAA.S324099. eCollection 2021. J Asthma Allergy. 2021. PMID: 34413654 Free PMC article.
Real world effectiveness of benralizumab on respiratory function and asthma control.
Menzella F, Fontana M, Galeone C, Ghidoni G, Capobelli S, Ruggiero P, Scelfo C, Simonazzi A, Catellani C, Livrieri F, Facciolongo NC. Menzella F, et al. Among authors: simonazzi a. Multidiscip Respir Med. 2021 Oct 4;16(1):785. doi: 10.4081/mrm.2021.785. eCollection 2021 Jan 15. Multidiscip Respir Med. 2021. PMID: 34733505 Free PMC article.
Omalizumab: when the non-responder is a late-responder.
Menzella F, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L. Menzella F, et al. Among authors: simonazzi a. Eur Ann Allergy Clin Immunol. 2009 Oct;41(5):155-9. Eur Ann Allergy Clin Immunol. 2009. PMID: 20101930
Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up.
Menzella F, Facciolongo N, Piro R, Formisano D, Roggeri A, Simonazzi A, Castagnetti C, Carbonelli C, Zucchi L. Menzella F, et al. Among authors: simonazzi a. Ther Adv Respir Dis. 2012 Apr;6(2):87-95. doi: 10.1177/1753465811429478. Epub 2012 Feb 9. Ther Adv Respir Dis. 2012. PMID: 22323442 Free article.
24 results